Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope

Sinai Samaritan Medical Center, Milwaukee, Wisconsin 53201.

The usefulness of esmolol in predicting the efficacy of treatment with an oral beta-adrenergic blocking agent was evaluated in 27 consecutive patients with neurocardiogenic syncope. Seventeen patients had a positive head-up tilt test response at baseline and 10 patients required intravenous isoproterenol for provocation of hypotension. All patients were then given a continuous esmolol infusion (500 micrograms/kg per min loading dose for 3 min followed by 300 micrograms/kg per min maintenance dose) and rechallenged with a head-up tilt test at baseline or with isoproterenol. Of the 17 patients with a positive baseline tilt test response, 11 continued to have a positive response to esmolol challenge. Sixteen patients (including all 10 patients with a positive tilt test response with isoproterenol) exhibited a negative response to upright tilt during esmolol infusion. Irrespective of their response to esmolol infusion, all patients had a follow-up tilt test with oral metoprolol after an interval of greater than or equal to 5 half-lives of the drug. All 16 patients (100%) with a negative tilt test response during esmolol infusion had a negative tilt test response with oral metoprolol. Of the 11 patients with a positive tilt test response during esmolol infusion, 10 (90%) continued to have a positive response with oral metoprolol. It is concluded that in the electrophysiology laboratory, esmolol can accurately predict the outcome of a head-up tilt response to oral metoprolol. This information may be helpful in formulating a therapeutic strategy at the initial head-up tilt test in patients with neurocardiogenic syncope.

This article has been cited by other articles:

				J. R. Kapoor Predicting the Effectiveness of Beta-Blocker Therapy in Vasovagal Syncope J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2372 - 2372. [Full Text] [PDF]

				M. P. Tan and S. W. Parry Reply J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2372 - 2373. [Full Text] [PDF]

				J. M. Stewart, J. Munoz, and A. Weldon Clinical and Physiological Effects of an Acute {alpha}-1 Adrenergic Agonist and a {beta}-1 Adrenergic Antagonist in Chronic Orthostatic Intolerance Circulation, December 3, 2002; 106(23): 2946 - 2954. [Abstract] [Full Text] [PDF]

				P. Flevari, E. G. Livanis, G. N. Theodorakis, E. Zarvalis, T. Mesiskli, and D. T. h Kremastinos Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being J. Am. Coll. Cardiol., August 7, 2002; 40(3): 499 - 504. [Abstract] [Full Text] [PDF]

				A. H. Madrid, J. Ortega, J. G. Rebollo, J. G. Manzano, J. G. Segovia, A. Sanchez, G. Pena, and C. Moro Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study J. Am. Coll. Cardiol., February 1, 2001; 37(2): 554 - 559. [Abstract] [Full Text] [PDF]

				J. S. Sra Can we assess the efficacy of therapy in neurocardiogenic syncope? J. Am. Coll. Cardiol., February 1, 2001; 37(2): 560 - 561. [Full Text] [PDF]

				S.W. Parry and R.A. Kenny The management of vasovagal syncope QJM, December 1, 1999; 92(12): 697 - 705. [Full Text] [PDF]

				R. L. Kahn and M. J. Hargett {beta}-Adrenergic Blockers and Vasovagal Episodes During Shoulder Surgery in the Sitting Position Under Interscalene Block Anesth. Analg., February 1, 1999; 88(2): 378 - 378. [Abstract] [Full Text] [PDF]

				A. K. Younoszai, W. H. Franklin, D. P. Chan, S. C. Cassidy, and H. D. Allen Oral Fluid Therapy: A Promising Treatment for Vasodepressor Syncope Arch Pediatr Adolesc Med, February 1, 1998; 152(2): 165 - 168. [Abstract] [Full Text] [PDF]

				F. Karim and S. M. Poucher beta -Adrenoceptors in vascular capacitance responses to unloading of carotid baroreceptors in anesthetized dogs Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1713 - H1718. [Abstract] [Full Text] [PDF]

				M. Ovadia, K. Gear, D. Thoele, and F. I. Marcus Accelerometer Systolic Time Intervals as Fast-Response Sensors of Upright Posture in the Young Circulation, October 1, 1995; 92(7): 1849 - 1859. [Abstract] [Full Text]

				I. Bou-Holaigah, P. C. Rowe, J. Kan, and H. Calkins The Relationship Between Neurally Mediated Hypotension and the Chronic Fatigue Syndrome JAMA, September 27, 1995; 274(12): 961 - 967. [Abstract] [PDF]

				A. Natale, M. Akhtar, M. Jazayeri, A. Dhala, Z. Blanck, S. Deshpande, A. Krebs, and J. S. Sra Provocation of Hypotension During Head-Up Tilt Testing in Subjects With No History of Syncope or Presyncope Circulation, July 1, 1995; 92(1): 54 - 58. [Abstract] [Full Text]

				G. E. Tonnessen, J. I. Haft, J. Fulton, and D. G. Rubenstein The Value of Tilt Table Testing With Isoproterenol in Determining Therapy in Adults With Syncope and Presyncope of Unexplained Origin Arch Intern Med, July 25, 1994; 154(14): 1613 - 1617. [Abstract] [PDF]